Key facts
- This page summarizes Timothy C. Fiori's Form 4 filing for IMMUCELL CORP /DE/ (ICCC).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Apr 2025, 12:53.
Timothy C. Fiori - 16 Apr 2025 Form 4 Insider Report for IMMUCELL CORP /DE/ (ICCC)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ICCC
- Reported as of
- 16 Apr 2025
- Net transaction value
- +$164,700
- SEC form
- 4
- Accepted by SEC
- 23 Apr 2025, 12:53:40 UTC
- Prior SEC filing
- 07 Apr 2025
- Next SEC filing
- 29 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael F. Brigham
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Timothy C. Fiori filed Form 4 for IMMUCELL CORP /DE/ (ICCC) on 23 Apr 2025.
Change
- Previous filing in this sequence was filed on 07 Apr 2025.
- Current net transaction value: +$164,700.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ICCC
transaction
Derivative
Incentive Stock Options (Right to buy)
Award
- Transaction value
- $164,700
- Shares
- +30,000
- Change %
- Price
- $5.49
- Shares after
- 30,000
- Date
- 16 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $5.49
* marks a reported price that did not pass the local price check.